Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy
Authors:
- Hanaa H. AhmedHAHanaa H. Ahmed
- Atef A. BassyouniABAtef A. Bassyouni
- Amira S. AhmedAAAmira S. Ahmed
- 1 June 2012
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 45 (9) , 646-650
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it?Journal of Cell Communication and Signaling, 2009
- The Role of chemokines and chemokine receptors in diabetic nephropathyFrontiers in Bioscience-Landmark, 2008
- Transforming growth factor-β/connective tissue growth factor axis in the kidneyThe International Journal of Biochemistry & Cell Biology, 2008
- Diabetic Nephropathy: Mechanisms of Renal Disease ProgressionExperimental Biology and Medicine, 2008
- All in the CCN family: essential matricellular signaling modulators emerge from the bunkerJournal of Cell Science, 2006
- Global Prevalence of DiabetesDiabetes Care, 2004
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2003
- Increased levels of markers of vascular inflammation in patients with coronary heart diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2002
- Management of Diabetes MellitusDisease Management and Health Outcomes, 2001
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976